TGTX
TG THERAPEUTICS
Health Care·Biotechnology·UNITED STATES
$50.56
MCap $7.7B
as of 2026-08-20
Total
B3w
Fund
C3w
Quant
A9w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
+0.26
Sentiment 26.0%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$50.56
Adaptive Mean
$50.03
+0.53 vs mean
Adaptive σ
1.01
MIDOS BB
$48.02 – $52.04
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-21
Composite Z
+1.00
ROE
100.3%
Z +2.16
Rev Gr
70.3%
Z +0.29
EPS Gr
-70.6%
Z +4.42
OPM Gr
-15.7%
Z +0.59
FCF Yld
0.7%
Z +0.06
EPS Surp
-0.9%
Z -0.65
EPS 3mo Δ
103.8%
Z +0.13
Fwd P/E
18.44
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
12.87
Q6M
12.18
Q12M
7.47
MA 30/100
1.159
Bullish (MA30 > MA100)
α (Jensen)
1.0752
β (12M)
0.61
σ (12M)
0.452
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
98%
Q Percentile
90%
Divergence
+7.8
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
65.2
RS Pctl
94%
RS Decile
D10
Persistence
3w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.